HISUN(SH:600267) Zheng Quan Shi Bao Wang·2026-01-13 08:52Group 1 - On January 12, Haizheng Pharmaceutical announced a board resolution to establish a joint venture with Zhongyu Pet Food to enter the pet prescription food market [1] - The joint venture, named Zhejiang Haizheng Zhongyu Animal Nutrition Technology Co., Ltd., will be co-funded with a total investment of approximately 236 million yuan, with Haizheng holding 60% and Zhongyu holding 40% [1] - The partnership aims to integrate resources and develop the pet prescription food market, with a focus on creating a comprehensive health management platform for pets [2] Group 2 - The strategic cooperation signing ceremony highlighted the goal of rapidly introducing prescription food products within 1-2 years and expanding the product matrix within 3-5 years [2] - Zhongyu Pet Food, recognized as a national high-tech enterprise, anticipates revenues exceeding 600 million yuan and net profits over 70 million yuan in 2024 [1] - The collaboration will leverage Zhongyu's manufacturing strengths and Haizheng's market presence to enhance the development and distribution of prescription pet food [2][3] Group 3 - The global prescription pet food market is projected to reach approximately 21.24 billion USD in 2024, with an expected compound annual growth rate of 9.63% until 2029 [4] - The partnership aims to create a "three-in-one" pet health solution by combining prescription food with pharmaceuticals and health products, while also focusing on veterinary education [4]